PRECIGEN, INC. Increase (Decrease) in Accounts Payable, Trade
PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Accounts Payable, Trade of -$6.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-04
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $2.84M, a 254.43% increase year-over-year.
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was -$9.51M.
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $6.54M.
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $1.55M.
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for fiscal 2025 was $8.77M, a 466.04% increase from fiscal 2024.
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for fiscal 2024 was $1.55M.
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was -$2.42M, a 738.79% decline from fiscal 2022.
- PRECIGEN, INC. increase (decrease) in accounts payable, trade for fiscal 2022 was $379.00K, a 9.76% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 6 month as first filed | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$6.67M 10-Q · filed 2026-08-04 | -$138.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.41M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | -$9.51M 10-Q · filed 2026-05-13 | -$2.98M derived: sum of 2 quarters · filed 2026-05-13 | -$1.43M derived: sum of 3 quarters · filed 2026-05-13 | -$628.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $8.08M derived: sum of 2 quarters · filed 2026-03-25 | $8.88M derived: sum of 3 quarters · filed 2026-08-04 | $8.77M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.35M derived: sum of 2 quarters · filed 2026-08-04 | $2.23M 10-Q · filed 2025-11-13 | $1.44M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $801.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $684.00K 10-Q · filed 2026-08-04 | -$104.00K derived: sum of 3 quarters · filed 2026-08-04 | -$945.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | -$117.00K 10-Q · filed 2026-05-13 | -$905.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.75M derived: sum of 3 quarters · filed 2026-05-13 | -$1.22M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.63M derived: sum of 2 quarters · filed 2026-03-25 | -$1.10M derived: sum of 3 quarters · filed 2026-03-25 | $1.55M 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$841.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$316.00K derived: sum of 2 quarters · filed 2025-11-13 | $2.34M 10-Q · filed 2025-11-13 | $1.68M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2024-06-30 | $525.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $3.18M 10-Q · filed 2025-08-12 | $2.52M derived: sum of 3 quarters · filed 2026-03-25 | $2.29M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2024-03-31 | $2.65M 10-Q · filed 2025-05-14 | $1.99M derived: sum of 2 quarters · filed 2026-03-25 | $1.77M derived: sum of 3 quarters · filed 2026-03-25 | $481.00K derived: sum of 4 quarters · filed 2026-03-25 | |
| 2023-12-31 | -$662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$885.00K derived: sum of 2 quarters · filed 2026-03-25 | -$2.17M derived: sum of 3 quarters · filed 2026-03-25 | -$2.42M 10-K · filed 2026-03-25 | |
| 2023-09-30 | -$223.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.51M derived: sum of 2 quarters · filed 2024-11-14 | -$1.76M 10-Q · filed 2024-11-14 | -$2.11M derived: sum of 4 quarters · filed 2025-03-19 | |
| 2023-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.54M 10-Q · filed 2024-08-14 | -$1.54M 10-Q · filed 2023-08-09 | -$1.89M derived: sum of 3 quarters · filed 2025-03-19 | -$194.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | -$249.00K 10-Q · filed 2024-05-14 | -$598.00K derived: sum of 2 quarters · filed 2025-03-19 | $1.09M derived: sum of 3 quarters · filed 2025-03-19 | $718.00K derived: sum of 4 quarters · filed 2025-03-19 | |
| 2022-12-31 | -$349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $1.34M derived: sum of 2 quarters · filed 2025-03-19 | $967.00K derived: sum of 3 quarters · filed 2025-03-19 | $379.00K 10-K · filed 2025-03-19 | |
| 2022-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.32M derived: sum of 2 quarters · filed 2023-11-09 | $728.00K 10-Q · filed 2023-11-09 | $1.83M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-06-30 | -$375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$963.00K 10-Q · filed 2023-08-09 | $135.00K derived: sum of 3 quarters · filed 2024-03-19 | -$1.06M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-03-31 | -$588.00K 10-Q · filed 2023-05-10 | $510.00K derived: sum of 2 quarters · filed 2024-03-19 | -$690.00K derived: sum of 3 quarters · filed 2024-03-19 | $21.00K derived: sum of 4 quarters · filed 2024-03-19 | |
| 2021-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$102.00K derived: sum of 2 quarters · filed 2024-03-19 | $609.00K derived: sum of 3 quarters · filed 2024-03-19 | $420.00K 10-K · filed 2024-03-19 | |
| 2021-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$489.00K derived: sum of 2 quarters · filed 2022-11-09 | -$678.00K 10-Q · filed 2022-11-09 | -$219.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | $711.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $522.00K 10-Q · filed 2022-08-08 | $981.00K derived: sum of 3 quarters · filed 2023-03-06 | $1.38M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | -$189.00K 10-Q · filed 2022-05-09 | $270.00K derived: sum of 2 quarters · filed 2023-03-06 | $669.00K derived: sum of 3 quarters · filed 2023-03-06 | -$369.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $858.00K derived: sum of 2 quarters · filed 2023-03-06 | -$180.00K derived: sum of 3 quarters · filed 2023-03-06 | -$1.10M 10-K · filed 2023-03-06 | |
| 2020-09-30 | $399.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$639.00K derived: sum of 2 quarters · filed 2021-11-08 | -$1.56M 10-Q · filed 2021-11-08 | -$2.47M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.96M 10-Q · filed 2021-08-09 | -$2.87M derived: sum of 3 quarters · filed 2022-03-01 | -$3.62M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$917.00K 10-Q · filed 2021-05-10 | -$1.83M derived: sum of 2 quarters · filed 2022-03-01 | -$2.58M derived: sum of 3 quarters · filed 2022-03-01 | -$5.03M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.66M derived: sum of 2 quarters · filed 2022-03-01 | -$4.11M derived: sum of 3 quarters · filed 2022-03-01 | -$5.35M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$3.19M derived: sum of 2 quarters · filed 2020-11-09 | -$4.43M 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$3.69M 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | -$1.24M 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $4.68M 10-K · filed 2021-03-01 | ||||
| 2017-12-31 | -$3.40M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |